Medlab Clinical LTD sell "NanaBidial™"

NanaBidial is an investigational sub-micron oro-buccal spray delivering roughly an 18:1 ratio of cannabidiol (CBD) to delta-9-THC (approximately 20 mg/mL CBD and under 1 mg/mL THC), built on the NanoCelle transmucosal delivery platform. It has been evaluated in a completed exploratory pilot study assessing the safety, tolerability, and pharmacokinetics of buccal CBD administration in healthy volunteers (ANZCTR ACTRN12617001491358), and is covered by an Australian transmucosal/transdermal delivery patent.